Effect of Glucose-Insulin-Potassium in Creatine Phosphokinase (CPK)
Not Applicable
Recruiting
- Conditions
- Trauma, Rhabdomyolysis.
- Registration Number
- IRCT20211220053468N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Trauma patient
More than 18 years old
Satisfaction with participation in the study
CPK>3000
Urine output = 0.5 cc/kg/hour
Exclusion Criteria
Absence of Angina, history of Malignant Hyperthermia, history of Myocarditis, Muscular Dystrophy, Rheumatoid Arthritis, Liver disease, Connective tissue disease, Heart failure
Absence of Shock( BP more than 90 mmHg)
Absence of Hypo- or Hyperglycemia( BS 100-250)
Absence of Hypo- or Hyperkalemia( K 2.8 - 5)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evel of blood creatine phosphokinase (CPK). Timepoint: Creatine phosphokinase (CPK) blood levels are measured on the first day of the study (before the intervention) and on the first and second days after. Method of measurement: Creatine phosphokinase levels in blood samples are measured in a hospital laboratory.
- Secondary Outcome Measures
Name Time Method Blood creatinine level. Timepoint: Creatinine blood levels are measured on the first day of the study (before the intervention) and on the first and second days after. Method of measurement: Blood samples are measured in hospital laboratory.;Blood potassium. Timepoint: Blood potassium levels are measured on the first day of the study (before the intervention) and on the first and second days after. Method of measurement: Blood samples are measured in hospital laboratory.;Blood sugar. Timepoint: Blood sugar levels are measured on the first day of the study (before the intervention) and on the first and second days after. Method of measurement: Blood samples are measured in hospital laboratory.